ArticleACS omega2025

Discovery of Palazestrant (OP-1250), a Potent and Orally Bioavailable Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD).

Raymond A Ng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.